Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Biochimica Et Biophysica Acta. Reviews on Cancer|January 10, 2020
BRCA1/P53: Two strengths in cancer chemopreventionLiliana Raimundo, Helena Ramos, Joana B Loureiro, et al.Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Structure-Activity Relationship Studies of Chalcones and Diarylpentanoids with Antitumor Activity: Potency and Selectivity OptimizationJoana Moreira, Joana B Loureiro, Danilo Correia, et al.Molecules (Basel, Switzerland)|September 23, 2022
Amaryllidaceae-Type Alkaloids from Pancratium maritimum: Apoptosis-Inducing Effect and Cell Cycle Arrest on Triple-Negative Breast Cancer CellsShirley A R Sancha, Adriana V Gomes, Joana B Loureiro, et al.British Journal of Pharmacology|August 5, 2018
Improving anticancer activity towards colon cancer cells with a new p53-activating agentLiliana Raimundo, Margarida Espadinha, Joana Soares, et al.Chemmedchem|June 25, 2021
A Diarylpentanoid with Potential Activation of the p53 Pathway: Combination of in silico Screening Studies, Synthesis, and Biological Activity EvaluationJoana Moreira, Joana Almeida, Joana B Loureiro, et al.Molecules (Basel, Switzerland)|April 3, 2021
Semi-Synthesis of Small Molecules of Aminocarbazoles: Tumor Growth Inhibition and Potential Impact on p53Solida Long, Joana B Loureiro, Carla Carvalho, et al.Pharmaceuticals (Basel, Switzerland)|December 23, 2022
3-(1,2,3-Triazol-4-yl)-β-Carbolines and 3-(1H-Tetrazol-5-yl)-β-Carbolines: Synthesis and Evaluation as Anticancer AgentsJoão L P Ribeiro, Joana B Loureiro, Susana M M Lopes, et al.Molecules (Basel, Switzerland)|May 25, 2019
Synthesis, Biological Evaluation, and In Silico Studies of Novel Aminated Xanthones as Potential p53-Activating AgentsAgostinho Lemos, Ana Sara Gomes, Joana B Loureiro, et al.Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 ActivatorsValentina Barcherini, Joana B Loureiro, Ana Sena, et al.European Journal of Medicinal Chemistry|July 25, 2018
Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activityPedro Brandão, Joana B Loureiro, Sylvie Carvalho, et al.Pageof 2